Why the study?
Does heart transplantation provide similar survival outcomes in patients with end-stage valvular heart disease compared to other indications?
Does heart transplantation provide similar survival outcomes in patients with end-stage valvular heart disease compared to other indications?
Answers are grounded in this paper and cite their sources.
Heart transplantation for end-stage valvular heart disease yields long-term survival outcomes comparable to those for other indications.
BACKGROUND: In general, heart transplantation for patients with heart failure improves survival. However, the outcomes of heart transplantation for patients with end-stage valvular heart disease are less well reported. This is a substantial group of patients, many of whom have had previous cardiac surgery. They therefore may be considered a subgroup with a poor prognosis. This study reports on the outcomes of heart transplantation for patients with end-stage valvular heart disease. PATIENTS AND METHODS: From March 1989 to December 2004, 75 consecutive adult heart transplantations were performed for end-stage valvular heart disease. Clinical characteristics were retrieved from a computerized database. RESULTS: The early mortality risk in heart transplantation for end-stage valvular heart disease was 13%, compared to 8% for other indications (p = 0.12). The main causes of early death were rejection (20%) and right ventricular failure (20%). The total follow-up time was 415 patient-years. During the follow-up, another 23 patients died (55/1000 patient-years of late mortality rate), mostly due to infection (43%) and multiorgan failure (22%). Multivariable analysis demonstrated that increased waiting time to heart transplantation correlated with increased survival (HR = 0.998, p = 0.04). The survival at 1, 5, 10, and 15 years was 70%, 64%, 56%, and 46% compared to 78%, 68%, 53%, and 41% for other indications, respectively (p = 0.5). CONCLUSION: The outcomes of heart transplantation for patients with end-stage valvular heart disease are similar to those for other patients. Apparently, the longer the waiting time to heart transplantation the better the outcome becomes.
No takes yet. Share an insight, caveat, or question.
Tjang et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: